LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,173
تعداد مقالات10,718
تعداد مشاهده مقاله64,176,810
تعداد دریافت فایل اصل مقاله12,390,256
Kadeh, Hamideh, Baranzehi, Tayebeh, Mollaali, Milad, Maserat, Neda, Shahraki, Mohammad-Javad, Kordi-Tamandani, Dor Mohammad. (1403). Correlation between JAK2, STAT3, and CTLA4 Relative Gene Expressions and Oral Squamous Cell Carcinoma. سامانه مدیریت نشریات علمی, 26(1), 25-32. doi: 10.30476/dentjods.2024.100237.2205
Hamideh Kadeh; Tayebeh Baranzehi; Milad Mollaali; Neda Maserat; Mohammad-Javad Shahraki; Dor Mohammad Kordi-Tamandani. "Correlation between JAK2, STAT3, and CTLA4 Relative Gene Expressions and Oral Squamous Cell Carcinoma". سامانه مدیریت نشریات علمی, 26, 1, 1403, 25-32. doi: 10.30476/dentjods.2024.100237.2205
Kadeh, Hamideh, Baranzehi, Tayebeh, Mollaali, Milad, Maserat, Neda, Shahraki, Mohammad-Javad, Kordi-Tamandani, Dor Mohammad. (1403). 'Correlation between JAK2, STAT3, and CTLA4 Relative Gene Expressions and Oral Squamous Cell Carcinoma', سامانه مدیریت نشریات علمی, 26(1), pp. 25-32. doi: 10.30476/dentjods.2024.100237.2205
Kadeh, Hamideh, Baranzehi, Tayebeh, Mollaali, Milad, Maserat, Neda, Shahraki, Mohammad-Javad, Kordi-Tamandani, Dor Mohammad. Correlation between JAK2, STAT3, and CTLA4 Relative Gene Expressions and Oral Squamous Cell Carcinoma. سامانه مدیریت نشریات علمی, 1403; 26(1): 25-32. doi: 10.30476/dentjods.2024.100237.2205

Correlation between JAK2, STAT3, and CTLA4 Relative Gene Expressions and Oral Squamous Cell Carcinoma

Journal of Dentistry
مقاله 4، دوره 26، شماره 1 - شماره پیاپی 86، خرداد 2025، صفحه 25-32    اصل مقاله (637.92 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/dentjods.2024.100237.2205
نویسندگان
Hamideh Kadeh* 1؛ Tayebeh Baranzehi2؛ Milad Mollaali2؛ Neda Maserat2؛ Mohammad-Javad Shahraki2؛ Dor Mohammad Kordi-Tamandani2
1Dept. Oral and Maxillofacial Pathology, Oral and Dental Disease Research Center, Faculty of Dentistry, Zahedan University of Medical Sciences, Zahedan, Iran.
2Dept. of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran.
چکیده
Statement of the Problem: Oral squamous cell carcinoma (OSCC) is the eighth leading cause of cancer-related death worldwide. JAK2 and STAT3 primarily influence intrinsic tumor cell behavior, and CTLA4 impacts the interplay between the tumor and the host immune system in the context of cancers. There is scarce information regarding the involvement and roles of JAK2, STAT3, and CTLA4 genes in OSCC; however, the molecular mechanisms are still unclear.
Purpose: This study examined the relationship between JAK2, STAT3, and CTLA4 gene expression levels and OSCC in a group of patients in the southeast of Iran.
Materials and Method: This cross-sectional study was conducted in which the relative gene expression levels of JAK2, STAT3, and CTLA4 were compared between 23 oral paraffin tissue blocks collected from OSCC patients and 20 fresh gingival tissues collected from healthy individuals. The Real-Time quantitative PCR (RT-qPCR) assay was employed to assess relative gene expression levels. SPSS 27 was employed to perform statistical analyses.
Results: Significant differences were found between OSCC patients and healthy individuals concerning gene expression levels of JAK2 (2.4-fold, p< 0.0001), STAT3 (2.32-fold, p< 0.0001), and CTLA4 (4.09-fold, p< 0.0001). Additionally, there were significant positive correlations among JAK2-STAT3 (0.667, p< 0.001), JAK2-CTLA4 (0.771, p< 0.001), and STAT3-CTLA4 (0.635, p= 0.001) co-expressions. Moreover, gender, age groups, and tumor locations did not significantly correlate with the expression levels of these genes (p> 0.05). Nevertheless, significant differences occurred between histopathological grades and the gene expression levels of JAK2 (p< 0.001), STAT3 (p= 0.001), and CTLA4 (p< 0.001).
Conclusion: The overexpression of JAK2, STAT3, and CTLA4 can be considered triggers for OSCC development. It may be beneficial to conduct future research on OSCC by considering downstream genes involved in the JAK2/STAT3/CTLA4 axis.
کلیدواژه‌ها
Squamous Cell Carcinoma of Head and Neck؛ Janus Kinase 2؛ STAT3 Transcription Factor؛ CTLA-4 Antigen؛ Gene Expression
سایر فایل های مرتبط با مقاله
مراجع
  • Ahmed SP, Jayan L, Dineshkumar T, Raman S. Oral squamous cell carcinoma under microscopic vision: A review of histological variants and its prognostic indicators. SRM J Res Dent Sci. 2019; 10: 90-97.
  • Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin. 2015; 65: 401-421.
  • Irani S. New Insights into Oral Cancer-Risk Factors and Prevention: A Review of Literature. Int J Prev Med. 2020; 11: 202.
  • Wang HQ, Man QW, Huo FY, Gao X, Lin H, Li SR, et al. STAT3 pathway in cancers: Past, present, and future. MedComm (2020). 2022; 3: e124.
  • Delgoffe GM, Vignali DA. STAT heterodimers in immunity: A mixed message or a unique signal? Jakstat. 2013; 2: e23060.
  • Yuan Zl, Guan YJ, Wang L, Wei W, Kane AB, Chin YE. Central role of the threonine residue within the p+ 1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol Cell Biol. 2004; 24: 9390-9400.
  • Galoczova M, Coates P, Vojtesek B. STAT3, stem cells, cancer stem cells and p63. Cell Mol Biol Lett. 2018; 23: 1-20.
  • Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J Exp Clin Cancer Res. 2019; 38: 1-12.
  • Chen H, Qi X, Bai X, Qiu P, Chen B. Role of CD152 genetic polymorphisms in the susceptibility to breast cancer. Oncotarget. 2017; 8: 26679-26686.
  • Verma N, Burns SO, Walker LS, Sansom DM. Immune deficiency and autoimmunity in patients with CTLA‐4 (CD152) mutations. Clin Exp Immunol. 2017; 190: 1-7.
  • Rigi-Ladiz MA, Baranzehi T, Hassanpour B, Ashraf MJ, Farhad-Mollashahi L, Kordi-Tamandani DM. DNA methylation and expression status of glutamate receptor genes in patients with oral squamous cell carcinoma. Meta Gene. 2019; 20: 100555.
  • Sengüven B, Baris E, Oygur T, Berktas M. Comparison of Methods for the Extraction of DNA from Formalin-Fixed, Paraffin-Embedded Archival Tissues. Int J Med Sci. 2014; 11: 494-499.
  • Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods. 2001; 25: 402-408.
  • Mishra P, Pandey CM, Singh U, Gupta A, Sahu C, Keshri A. Descriptive statistics and normality tests for statistical data. Ann Card Anaesth. 2019; 22: 67-72.
  • Santillán-Benítez JG, Mendieta-Zerón H, Gómez-Oliván LM, Ordóñez Quiroz A, Torres-Juárez JJ, González-Bañales JM. JAK2, STAT3 and SOCS3 gene expression in women with and without breast cancer. Gene. 2014; 547: 70-76.
  • Herrmann A, Lahtz C, Nagao T, Song JY, Chan WC, Lee H, et al. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity. Cancer Res. 2017; 77: 5118-5128.
  • Hsu P, Santner-Nanan B, Hu M, Skarratt K, Lee CH, Stormon M, et al. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1. J Immunol. 2015; 195: 3665-3674.
  • Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X. Targeting STAT3 in Cancer Immunotherapy. Mol Cancer. 2020; 19: 145.
  • Wu M, Song D, Li H, Yang Y, Ma X, Deng S, et al. Negative regulators of STAT3 signaling pathway in cancers. Cancer Manag Res. 2019; 11: 4957-4969.
  • Don-Doncow N, Marginean F, Coleman I, Nelson PS, Ehrnström R, Krzyzanowska A, et al. Expression of STAT3 in prostate cancer metastases. Eur Urol. 2017; 71: 313-316.
  • Haura EB, Zheng Z, Song L, Cantor A, Bepler G. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer. Clin Cancer Res. 2005; 11: 8288-8294.
  • Xiao L, Li X, Cao P, Fei W, Zhou H, Tang N, Liu Y. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/ STAT3/Sox4/NLRP3 signaling pathway. J Exp Clin Cancer Res. 2022; 41: 166.
  • Gkouveris I, Nikitakis N, Sauk J. STAT3 signaling in cancer. J Cancer Ther. 2015; 6: 709-726.
  • Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res. 2011; 9: 1658-1667.
  • Thomas S, Snowden J, Zeidler M, Danson S. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015; 113: 365-371.
  • Erfani N, Khademi B, Haghshenas MR, Mojtahedi Z, Khademi B, Ghaderi A. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. Immunol Invest. 2013; 42: 81-90.
  • Erfani N, Mehrabadi SM, Ghayumi MA, Haghshenas MR, Mojtahedi Z, Ghaderi A, et al. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung Cancer. 2012; 77: 306-311.
  • Antczak A, Pastuszak-Lewandoska D, Górski P, Domańska D, Migdalska-Sęk M, Czarnecka K, et al. Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer. Biomed Res Int. 2013; 2013: 1-8.
  • Padma R, Kalaivani A, Sundaresan S, Sathish P. The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2017; 21: 461.
  • Moreira G, Fulgêncio LB, DE Mendonça EF, Leles CR, Batista AC, DA Silva TA. T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness. Oncol Lett. 2010; 1: 127-132.
  • Jiang M, Li B. STAT3 and Its Targeting Inhibitors in Oral squamous cell carcinoma. Cells. 2022; 11: 3131.  
  • Oh HN, Seo JH, Lee MH, Kim C, Kim E, Yoon G, et al. Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/ STAT3 signaling pathway. J Cell Biochem. 2018; 119: 10118-10130.
  • Seo JH, Choi HW, Oh HN, Lee MH, Kim E, Yoon G, et al. Licochalcone D directly targets JAK2 to induced apoptosis in human oral squamous cell carcinoma. J Cell Physiol. 2019; 234: 1780-1793.
  • Oh HN, Oh KB, Lee MH, Seo JH, Kim E, Yoon G, et al. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma. Phytomedicine. 2019; 52: 60-69.
  • Callahan MK, Wolchok JD, Allison JP. Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy. Semin Oncol. 2010; 37: 473-484.
  • Xiao Y, Mao L, Yang QC, Wang S, Wu ZZ, Wan SC, et al. CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer. Oral Oncology. 2023; 138: 106331.
آمار
تعداد مشاهده مقاله: 498
تعداد دریافت فایل اصل مقاله: 306


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب